Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
21/05/2025
WhatsApp co-founder Brian Acton stated during the hearing that before the company was acquired by Mark Zuckerberg's Facebook, they had no intention of building social networking features to compete with Facebook.
Latest
2 m ago
CMB International Securities report states that Sanofi has signed the largest single asset transaction in the Chinese biopharmaceutical industry with Pfizer, with a prepayment of 1.25 billion US dollars and a total scale of 6 billion US dollars. The report indicates that the company had previously alerted investors about the potential license transfer of PD-1xVEGF and TL1A, with the further maturity of immunological assets expected to drive another round of valuation upgrades. Based on the company's rich product line, the company aims to launch around 10 products from this year to 2027 and submit new drug applications, continuously expand indications, develop internal new product lines, and expand verified business efforts in hair loss, skin diseases, and autoimmune product combinations. In addition, the company's ample cash position and continuously strengthened internal R&D team support the transformation. The bank maintains a "buy" rating on Sanofi with a target price raised to 25 Hong Kong dollars.
2 m ago
CMB International Securities: Raises Sinsomedicine's target price to 25 Hong Kong dollars, maintains "buy" rating.
4 m ago
The National Emergency Management Financial Work Conference of 2025 is held in Beijing.
5 m ago
The crew of Shen 20 spacecraft will soon carry out their first spacewalk.
6 m ago
The Trump administration in the United States is discussing an executive order that could open up nearly $9 trillion in the American retirement market to private capital groups.
See all latest